Prostate Cancer - Results from #24020

ASCO, ESMO, AUA, EAU, DGU - update urooncology: News with clinical relevance from major scientific meetings 2012 - Abstract January 17, 2013

Salvage hormonal therapy against recurrence after curative external beam radiotherapy for locally advanced prostate cancer at Kyoto University Hospital - Abstract January 17, 2013

Bladder neck preservation during classic laparoscopic radical prostatectomy - point of technique and preliminary results - Abstract January 17, 2013

Whole milk intake is associated with prostate cancer-specific mortality among U.S. male physicians - Abstract January 17, 2013

Neoadjuvant androgen deprivation therapy for prostate volume reduction, lower urinary tract symptom relief and quality of life improvement in men with intermediate- to high-risk prostate cancer: A randomised non-inferiority trial of degarelix versus goser January 17, 2013

Degarelix versus goserelin (+ antiandrogen flare protection) in the relief of lower urinary tract symptoms secondary to prostate cancer: Results from a phase IIIb study (NCT00831233) - Abstract January 17, 2013

Urinary tract-related quality of life after radical prostatectomy: Open retropubic versus robot-assisted laparoscopic approach - Abstract January 17, 2013

Risk stratification in prostate cancer screening - Abstract January 17, 2013

Recent trends in prostate cancer incidence by age, cancer stage, and grade, the United States, 2001-2007 - Abstract January 17, 2013

Diagnostic role of (18)F-FECH-PET/CT compared with bone scan in evaluating the prostate cancer patients referring with biochemical recurrence - Abstract January 17, 2013

Triptorelin in the management of prostate cancer - Abstract January 17, 2013

Limitations of basing screening policies on screening trials: The US Preventive Services Task Force and prostate cancer screening - Abstract January 16, 2013

Neoadjuvant hormonal therapy is a feasible option in laparoscopic radical prostatectomy - Abstract January 16, 2013

Interscanner comparison of dynamic contrast-enhanced MRI in prostate cancer: 1.5 Versus 3 T MRI - Abstract January 16, 2013

Adaptation or selection-mechanisms of castration-resistant prostate cancer - Abstract January 16, 2013

Chemical biology drug sensitivity screen identifies sunitinib as synergistic agent with disulfiram in prostate cancer cells - Abstract January 16, 2013

A phase I dose escalation trial of vaccine replicon particles (VRP) expressing prostate-specific membrane antigen (PSMA) in subjects with prostate cancer - Abstract January 16, 2013

Osteoporosis in patients with breast and prostate cancer. Effect of disease and treatment modalities - Abstract January 16, 2013

Radiopaque marker motion during pre-treatment CBCT as a predictor of intra-fractional prostate movement - Abstract January 16, 2013

Physician evaluation of Internet health information on proton therapy for prostate cancer - Abstract January 16, 2013

Page 1202 of 1435